S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
66,000% upside on tiny biotech? (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
BREAKING: Tiny biotech successfully treats blindness (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
BREAKING: Tiny biotech successfully treats blindness (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
66,000% upside on tiny biotech? (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
BREAKING: Tiny biotech successfully treats blindness (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
BREAKING: Tiny biotech successfully treats blindness (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
66,000% upside on tiny biotech? (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
BREAKING: Tiny biotech successfully treats blindness (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
BREAKING: Tiny biotech successfully treats blindness (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
66,000% upside on tiny biotech? (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
BREAKING: Tiny biotech successfully treats blindness (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
BREAKING: Tiny biotech successfully treats blindness (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
NASDAQ:LBPH

Longboard Pharmaceuticals (LBPH) Short Interest Ratio & Short Volume

$4.90
-0.66 (-11.87%)
(As of 10/2/2023 ET)
Compare
Today's Range
$4.75
$5.87
50-Day Range
$4.90
$7.49
52-Week Range
$2.70
$10.29
Volume
58,337 shs
Average Volume
78,408 shs
Market Capitalization
$112.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.40

Longboard Pharmaceuticals Short Interest Data

Current Short Volume
569,600 shares
Previous Short Volume
633,900 shares
Change Vs. Previous Month
-10.14%
Dollar Volume Sold Short
$3.55 million
Short Interest Ratio / Days to Cover
8.3
Last Record Date
September 15, 2023
Outstanding Shares
22,980,000 shares
Float Size
18,650,000 shares
Short Percent of Float
3.05%
Today's Trading Volume
58,337 shares
Average Trading Volume
78,408 shares
Today's Volume Vs. Average
74%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Longboard Pharmaceuticals ?

Sign up to receive the latest short interest report for Longboard Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LBPH Short Interest Over Time

LBPH Days to Cover Over Time

LBPH Percentage of Float Shorted Over Time


Longboard Pharmaceuticals (NASDAQ:LBPH) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/2023569,600 shares $3.55 million -10.1%3.1%8.3 $6.23
8/31/2023633,900 shares $3.67 million -4.0%3.5%5.8 $5.79
8/15/2023660,300 shares $4.26 million +0.4%3.6%5.9 $6.45
7/31/2023657,800 shares $4.74 million -7.9%4.2%5.3 $7.20
7/15/2023714,400 shares $4.74 million -2.5%5.1%5.7 $6.64
6/30/2023732,800 shares $5.38 million +165.2%5.2%5.4 $7.34
6/15/2023276,300 shares $2.14 million +36.5%2.0%2.1 $7.76
5/31/2023202,400 shares $1.40 million +149.9%1.4%2.2 $6.93
5/15/202381,000 shares $718,470.00 +352.5%0.6%1 $8.87
4/30/202317,900 shares $148,212.00 +23.5%0.1%0.3 $8.28
4/15/202314,500 shares $88,160.00 +93.3%0.1%0.3 $6.08
3/31/20237,500 shares $30,075.00 -27.2%0.1%0.2 $4.01
3/15/202310,300 shares $49,337.00 -16.3%0.1%0.4 $4.79
2/28/202312,300 shares $62,238.00 -9.6%0.1%0.5 $5.06
2/15/202313,600 shares $67,864.00 -24.9%0.2%0.5 $4.99
1/31/202318,100 shares $77,106.00 +1.1%0.2%0.8 $4.26
1/15/202317,900 shares $105,699.50 +25.2%0.2%0.8 $5.91
12/30/202214,300 shares $46,618.00 -18.3%0.2%0.7 $3.26
12/15/202217,500 shares $70,350.00 -45.1%0.2%0.9 $4.02
11/30/202231,900 shares $171,303.00 -33.5%0.4%1.5 $5.37
11/15/202248,000 shares $227,520.00 +21.5%0.5%2.3 $4.74
10/31/202239,500 shares $146,150.00 -13.6%0.4%1.4 $3.70
10/15/202245,700 shares $150,810.00 -9.5%0.5%2.1 $3.30
9/30/202250,500 shares $187,860.00 +9.3%0.6%2.3 $3.72
9/15/202246,200 shares $198,660.00 +94.1%0.5%2.1 $4.30
8/31/202223,800 shares $79,730.00 -24.2%0.3%1.2 $3.35
8/15/202231,400 shares $133,921.00 -34.3%0.3%2 $4.27
7/31/202247,800 shares $160,608.00 +9.9%0.5%6.7 $3.36
7/15/202243,500 shares $143,115.00 -11.6%0.5%6.2 $3.29
6/30/202249,200 shares $152,028.00 -12.1%0.5%5.2 $3.09
6/15/202256,000 shares $235,200.00 -18.4%0.6%6.4 $4.20
5/31/202268,600 shares $352,604.00 +11.5%0.8%6.5 $5.14
5/15/202261,500 shares $276,750.00 -16.7%0.7%5.4 $4.50
4/30/202273,800 shares $356,653.26 -14.2%0.8%5.3 $4.83
4/15/202286,000 shares $429,140.00 -3.2%0.9%5.5 $4.99
3/31/202288,800 shares $474,192.00 +8.3%1.0%4.6 $5.34
3/15/202282,000 shares $415,740.00 -10.6%0.9%2.5 $5.07
2/28/202291,700 shares $420,903.00 -4.1%1.0%2.6 $4.59
2/15/202295,600 shares $477,044.00 +21.6%1.0%2.8 $4.99
1/31/202278,600 shares $330,120.00 -22.8%0.9%2.2 $4.20













LBPH Short Interest - Frequently Asked Questions

What is Longboard Pharmaceuticals' current short interest?

Short interest is the volume of Longboard Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of September 15th, investors have sold 569,600 shares of LBPH short. 3.05% of Longboard Pharmaceuticals' shares are currently sold short. Learn More on Longboard Pharmaceuticals' current short interest.

What is a good short interest ratio for Longboard Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LBPH shares currently have a short interest ratio of 8.0. Learn More on Longboard Pharmaceuticals's short interest ratio.

What is a good short interest percentage for Longboard Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.05% of Longboard Pharmaceuticals' floating shares are currently sold short.

Is Longboard Pharmaceuticals' short interest increasing or decreasing?

Longboard Pharmaceuticals saw a decline in short interest in September. As of September 15th, there was short interest totaling 569,600 shares, a decline of 10.1% from the previous total of 633,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Longboard Pharmaceuticals' float size?

Longboard Pharmaceuticals currently has issued a total of 22,980,000 shares. Some of Longboard Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Longboard Pharmaceuticals currently has a public float of 18,650,000 shares.

How does Longboard Pharmaceuticals' short interest compare to its competitors?

3.05% of Longboard Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Longboard Pharmaceuticals: Aadi Bioscience, Inc. (3.87%), Puma Biotechnology, Inc. (4.67%), InflaRx (0.43%), BioVie Inc. (14.92%), Annexon, Inc. (4.55%), XBiotech Inc. (1.37%), Altimmune, Inc. (12.41%), Decibel Therapeutics, Inc. (0.63%), Silverback Therapeutics, Inc. (3.70%), Design Therapeutics, Inc. (8.78%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($8.05 billion), T-Mobile US, Inc. ($3.94 billion), Charter Communications, Inc. ($3.77 billion), Occidental Petroleum Co. ($3.27 billion), Tractor Supply ($2.29 billion), Celsius Holdings, Inc. ($2.20 billion), Rivian Automotive, Inc. ($2.10 billion), Moderna, Inc. ($2.08 billion), Royal Caribbean Cruises Ltd. ($1.90 billion), and T. Rowe Price Group, Inc. ($1.90 billion). View all of the most shorted stocks.

What does it mean to sell short Longboard Pharmaceuticals stock?

Short selling LBPH is an investing strategy that aims to generate trading profit from Longboard Pharmaceuticals as its price is falling. LBPH shares are trading down $0.66 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Longboard Pharmaceuticals?

A short squeeze for Longboard Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LBPH, which in turn drives the price of the stock up even further.

How often is Longboard Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LBPH, twice per month. The most recent reporting period available is September, 15 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:LBPH) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -